BALLANCE DAVID JAMES (VP, Research and Sci. Affairs) received a stock award from PHASEBIO PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 11/23/2020ACC: 0001169245-20-000100
Officer· VP, Research and Sci. Affairs
Since Oct 2018
+919.00
Net shares
Net buyer
$2.8K
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
919.00 acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+919.00
Price / share
$3.00
Trade value
$2.76K
% of position
12.1%
11/20/2020
7.60K→8.52K
Total
Net shares
+919.00
Net value
$2.76K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/20/2020 | A · Award | +919.00 | $3.00 | $2.76K | 12.1% | 7.60K | 8.52K |
| Total | +919.00 | $2.76K | ||||||
Derivative Transactions0
No derivative transactions reported